Copyright Reports & Markets. All rights reserved.

Global Anti-Infective Vaccines Market Professional Survey Report 2019

Request for Sample of this report
Buy now

Table of Contents

    Executive Summary

      1 Industry Overview of Anti-Infective Vaccines

      • 1.1 Definition of Anti-Infective Vaccines
      • 1.2 Anti-Infective Vaccines Segment by Type
        • 1.2.1 Global Anti-Infective Vaccines Production Growth Rate Comparison by Types (2014-2025)
        • 1.2.2 Inactivated vaccines
        • 1.2.3 Conjugate vaccines
        • 1.2.4 Live/attenuated vaccines
      • 1.3 Anti-Infective Vaccines Segment by Applications
        • 1.3.1 Global Anti-Infective Vaccines Consumption Comparison by Applications (2014-2025)
        • 1.3.2 Bacterial diseases
        • 1.3.3 Viral diseases
      • 1.4 Global Anti-Infective Vaccines Overall Market
        • 1.4.1 Global Anti-Infective Vaccines Revenue (2014-2025)
        • 1.4.2 Global Anti-Infective Vaccines Production (2014-2025)
        • 1.4.3 North America Anti-Infective Vaccines Status and Prospect (2014-2025)
        • 1.4.4 Europe Anti-Infective Vaccines Status and Prospect (2014-2025)
        • 1.4.5 China Anti-Infective Vaccines Status and Prospect (2014-2025)
        • 1.4.6 Japan Anti-Infective Vaccines Status and Prospect (2014-2025)
        • 1.4.7 Southeast Asia Anti-Infective Vaccines Status and Prospect (2014-2025)
        • 1.4.8 India Anti-Infective Vaccines Status and Prospect (2014-2025)

      2 Manufacturing Cost Structure Analysis

      • 2.1 Raw Material and Suppliers
      • 2.2 Manufacturing Cost Structure Analysis of Anti-Infective Vaccines
      • 2.3 Manufacturing Process Analysis of Anti-Infective Vaccines
      • 2.4 Industry Chain Structure of Anti-Infective Vaccines

      3 Development and Manufacturing Plants Analysis of Anti-Infective Vaccines

      • 3.1 Capacity and Commercial Production Date
      • 3.2 Global Anti-Infective Vaccines Manufacturing Plants Distribution
      • 3.3 Major Manufacturers Technology Source and Market Position of Anti-Infective Vaccines
      • 3.4 Recent Development and Expansion Plans

      4 Key Figures of Major Manufacturers

      • 4.1 Anti-Infective Vaccines Production and Capacity Analysis
      • 4.2 Anti-Infective Vaccines Revenue Analysis
      • 4.3 Anti-Infective Vaccines Price Analysis
      • 4.4 Market Concentration Degree

      5 Anti-Infective Vaccines Regional Market Analysis

      • 5.1 Anti-Infective Vaccines Production by Regions
        • 5.1.1 Global Anti-Infective Vaccines Production by Regions
        • 5.1.2 Global Anti-Infective Vaccines Revenue by Regions
      • 5.2 Anti-Infective Vaccines Consumption by Regions
      • 5.3 North America Anti-Infective Vaccines Market Analysis
        • 5.3.1 North America Anti-Infective Vaccines Production
        • 5.3.2 North America Anti-Infective Vaccines Revenue
        • 5.3.3 Key Manufacturers in North America
        • 5.3.4 North America Anti-Infective Vaccines Import and Export
      • 5.4 Europe Anti-Infective Vaccines Market Analysis
        • 5.4.1 Europe Anti-Infective Vaccines Production
        • 5.4.2 Europe Anti-Infective Vaccines Revenue
        • 5.4.3 Key Manufacturers in Europe
        • 5.4.4 Europe Anti-Infective Vaccines Import and Export
      • 5.5 China Anti-Infective Vaccines Market Analysis
        • 5.5.1 China Anti-Infective Vaccines Production
        • 5.5.2 China Anti-Infective Vaccines Revenue
        • 5.5.3 Key Manufacturers in China
        • 5.5.4 China Anti-Infective Vaccines Import and Export
      • 5.6 Japan Anti-Infective Vaccines Market Analysis
        • 5.6.1 Japan Anti-Infective Vaccines Production
        • 5.6.2 Japan Anti-Infective Vaccines Revenue
        • 5.6.3 Key Manufacturers in Japan
        • 5.6.4 Japan Anti-Infective Vaccines Import and Export
      • 5.7 Southeast Asia Anti-Infective Vaccines Market Analysis
        • 5.7.1 Southeast Asia Anti-Infective Vaccines Production
        • 5.7.2 Southeast Asia Anti-Infective Vaccines Revenue
        • 5.7.3 Key Manufacturers in Southeast Asia
        • 5.7.4 Southeast Asia Anti-Infective Vaccines Import and Export
      • 5.8 India Anti-Infective Vaccines Market Analysis
        • 5.8.1 India Anti-Infective Vaccines Production
        • 5.8.2 India Anti-Infective Vaccines Revenue
        • 5.8.3 Key Manufacturers in India
        • 5.8.4 India Anti-Infective Vaccines Import and Export

      6 Anti-Infective Vaccines Segment Market Analysis (by Type)

      • 6.1 Global Anti-Infective Vaccines Production by Type
      • 6.2 Global Anti-Infective Vaccines Revenue by Type
      • 6.3 Anti-Infective Vaccines Price by Type

      7 Anti-Infective Vaccines Segment Market Analysis (by Application)

      • 7.1 Global Anti-Infective Vaccines Consumption by Application
      • 7.2 Global Anti-Infective Vaccines Consumption Market Share by Application (2014-2019)

      8 Anti-Infective Vaccines Major Manufacturers Analysis

      • 8.1 Emergent BioDefense Operations Lansing Inc.
        • 8.1.1 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production Sites and Area Served
        • 8.1.2 Emergent BioDefense Operations Lansing Inc. Product Introduction, Application and Specification
        • 8.1.3 Emergent BioDefense Operations Lansing Inc. Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.1.4 Main Business and Markets Served
      • 8.2 Sanofi Pasteur
        • 8.2.1 Sanofi Pasteur Anti-Infective Vaccines Production Sites and Area Served
        • 8.2.2 Sanofi Pasteur Product Introduction, Application and Specification
        • 8.2.3 Sanofi Pasteur Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.2.4 Main Business and Markets Served
      • 8.3 Merck & Co.
        • 8.3.1 Merck & Co. Anti-Infective Vaccines Production Sites and Area Served
        • 8.3.2 Merck & Co. Product Introduction, Application and Specification
        • 8.3.3 Merck & Co. Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.3.4 Main Business and Markets Served
      • 8.4 MedImmune LLC
        • 8.4.1 MedImmune LLC Anti-Infective Vaccines Production Sites and Area Served
        • 8.4.2 MedImmune LLC Product Introduction, Application and Specification
        • 8.4.3 MedImmune LLC Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.4.4 Main Business and Markets Served
      • 8.5 Novartis Vaccines
        • 8.5.1 Novartis Vaccines Anti-Infective Vaccines Production Sites and Area Served
        • 8.5.2 Novartis Vaccines Product Introduction, Application and Specification
        • 8.5.3 Novartis Vaccines Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.5.4 Main Business and Markets Served
      • 8.6 Diagnostics Ltd.
        • 8.6.1 Diagnostics Ltd. Anti-Infective Vaccines Production Sites and Area Served
        • 8.6.2 Diagnostics Ltd. Product Introduction, Application and Specification
        • 8.6.3 Diagnostics Ltd. Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.6.4 Main Business and Markets Served
      • 8.7 Intercell Biomedical
        • 8.7.1 Intercell Biomedical Anti-Infective Vaccines Production Sites and Area Served
        • 8.7.2 Intercell Biomedical Product Introduction, Application and Specification
        • 8.7.3 Intercell Biomedical Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.7.4 Main Business and Markets Served
      • 8.8 MassBiologics
        • 8.8.1 MassBiologics Anti-Infective Vaccines Production Sites and Area Served
        • 8.8.2 MassBiologics Product Introduction, Application and Specification
        • 8.8.3 MassBiologics Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.8.4 Main Business and Markets Served
      • 8.9 Barr Labs, Inc.
        • 8.9.1 Barr Labs, Inc. Anti-Infective Vaccines Production Sites and Area Served
        • 8.9.2 Barr Labs, Inc. Product Introduction, Application and Specification
        • 8.9.3 Barr Labs, Inc. Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.9.4 Main Business and Markets Served
      • 8.10 Organon Teknika Co.
        • 8.10.1 Organon Teknika Co. Anti-Infective Vaccines Production Sites and Area Served
        • 8.10.2 Organon Teknika Co. Product Introduction, Application and Specification
        • 8.10.3 Organon Teknika Co. Anti-Infective Vaccines Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
        • 8.10.4 Main Business and Markets Served
      • 8.11 GlaxoSmithKline Biologicals
      • 8.12 CSL Ltd.
      • 8.13 ID Biomedical Co.
      • 8.14 Protein Sciences Co.
      • 8.15 Wyeth Pharmaceuticals, Inc.
      • 8.16 Berna Biotech

      9 Development Trend of Analysis of Anti-Infective Vaccines Market

      • 9.1 Global Anti-Infective Vaccines Market Trend Analysis
        • 9.1.1 Global Anti-Infective Vaccines Market Size (Volume and Value) Forecast 2019-2025
      • 9.2 Anti-Infective Vaccines Regional Market Trend
        • 9.2.1 North America Anti-Infective Vaccines Forecast 2019-2025
        • 9.2.2 Europe Anti-Infective Vaccines Forecast 2019-2025
        • 9.2.3 China Anti-Infective Vaccines Forecast 2019-2025
        • 9.2.4 Japan Anti-Infective Vaccines Forecast 2019-2025
        • 9.2.5 Southeast Asia Anti-Infective Vaccines Forecast 2019-2025
        • 9.2.6 India Anti-Infective Vaccines Forecast 2019-2025
      • 9.3 Anti-Infective Vaccines Market Trend (Product Type)
      • 9.4 Anti-Infective Vaccines Market Trend (Application)
      • 10.1 Marketing Channel
        • 10.1.1 Direct Marketing
        • 10.1.2 Indirect Marketing
      • 10.3 Anti-Infective Vaccines Customers

      11 Market Dynamics

      • 11.1 Market Trends
      • 11.2 Opportunities
      • 11.3 Market Drivers
      • 11.4 Challenges
      • 11.5 Influence Factors

      12 Conclusion

        13 Appendix

        • 13.1 Methodology/Research Approach
          • 13.1.1 Research Programs/Design
          • 13.1.2 Market Size Estimation
          • 13.1.3 Market Breakdown and Data Triangulation
        • 13.2 Data Source
          • 13.2.1 Secondary Sources
          • 13.2.2 Primary Sources
        • 13.3 Author List

        Anti-infective vaccines are the most effective public health measure taken to fight infectious diseases.

        The global Anti-Infective Vaccines market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
        This report focuses on Anti-Infective Vaccines volume and value at global level, regional level and company level. From a global perspective, this report represents overall Anti-Infective Vaccines market size by analyzing historical data and future prospect.
        Regionally, this report categorizes the production, apparent consumption, export and import of Anti-Infective Vaccines in North America, Europe, China, Japan, Southeast Asia and India.
        For each manufacturer covered, this report analyzes their Anti-Infective Vaccines manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

        The following manufacturers are covered:
        Emergent BioDefense Operations Lansing Inc.
        Sanofi Pasteur
        Merck & Co.
        MedImmune LLC
        Novartis Vaccines
        Diagnostics Ltd.
        Intercell Biomedical
        MassBiologics
        Barr Labs, Inc.
        Organon Teknika Co.
        GlaxoSmithKline Biologicals
        CSL Ltd.
        ID Biomedical Co.
        Protein Sciences Co.
        Wyeth Pharmaceuticals, Inc.
        Berna Biotech

        Segment by Regions
        North America
        Europe
        China
        Japan
        Southeast Asia
        India

        Segment by Type
        Inactivated vaccines
        Conjugate vaccines
        Live/attenuated vaccines

        Segment by Application
        Bacterial diseases
        Viral diseases

        Buy now